Gait disturbances in patients with schizophrenia and adaptation to treadmill walking

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 3, 2005, Pages 303-310

  Putzhammer, Albert ^a   Perfahl, Maria ^a   Pfeiff, Liane ^a   Hajak, Göran ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Antipsychotic agents; Extrapyramidal side effects; Gait; Hypokinesia; Movement disorder; Schizophrenia; Treadmill walking

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT; GAIT DISORDER; HUMAN; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARAMETER; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TREADMILL; VELOCITY; WALKING;

ADAPTATION, PHYSIOLOGICAL; ADULT; ALGORITHMS; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL STIMULATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; WALKING;

EID: 21244475103     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01375.x     Document Type: Article

References (33)

1. King HE. Psychomotor correlates of behavior disorder. In: Kietzmann ML, Sutton S, Zubin J (eds). Experimental Approaches to Psychopathology. Academic Press, New York, 1976, 421-450.
2. Schroder J, Niethammer R, Geider FJ et al. Neurological soft signs in schizophrenia. Schizophr. Res. 1991; 6: 25-30.
3. Davalos DB, Compagnon N, Heinlein S, Ross RG. Neuropsychological deficits in children associated with increased familial risk for schizophrenia. Schizophr. Res. 2004; 67: 123-130.
4. Hawkins KA, Addington J, Keefe RS et al. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr. Res. 2004; 67: 115-122.
5. Sevincok L, Akoglu A, Topaloglu B, Aslantas H. Neurological soft signs in schizophrenic patients with obsessive-compulsive disorder. Psychiatry Clin. Neurosci. 2004; 58: 274-279.
6. Putzhammer A, Heindl B, Broll K, Pfeiff L, Perfahl M, Hajak G. Spatial and temporal parameters of gait disturbances in schizophrenic patients. Schizophr. Res. 2004; 69: 159-166.
7. Morris M, Iansek R, Matyas T, Summers J. Abnormalities in the stride length-cadence relation in parkinsonian gait. Mov. Disord. 1998; 13: 61-69.
8. Brown RG, Marsden CD. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988; 111: 323-345.
9. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13: 261-276.
10. Chouinard G, Ross-Chouinard A, Annable L, Jones BD. The extrapyramidal symptoms rating scale. Can. J. Neurol. Sci. 1980; 7: 233-244.
11. Guy W. Abnormal involuntary movement scale (AIMS). ECDEU Assessment Manual for Psychopharmacology. Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Washington, DC, 1976.
12. Putzhammer A, Mueller J, Heindl B et al. Threedimensional ultasonic gait analysis in schizophrenic patients. Psychiatr. Prax. 2003; 30: 110-114.
13. Lemke MR, Wendorff T, Mieth B, Buhl K, Linnemann M. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J. Psychiatr. Res. 2000; 34: 277-283.
14. Delong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990; 13: 281-285.
15. Rascol O, Sabatini U, Chollet F et al. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch. Neurol. 1992; 49: 144-148.
16. Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp. Brain Res. 1991; 84: 393-402.
17. Braus DF, Ende G, Weber-Fahr W et al. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr. Res. 1999; 39: 19-29.
18. Mueller J, Roeder C, Schuirer G, Klein HE. Subcortical overactivation in untreated schizophrenic patiens: a functional magnetic resonance image finger-tapping study. Psychiatry Clin. Neurosci. 2002; 56: 77-84.
19. Schroder J, Wenz F, Schad LR, Baudendistel K, Knopp MV. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. Br. J. Psychiatry 1995; 167: 197-201.
20. Clinton SM, Meador-Woodruff JH. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 2004; 69: 237-253.
21. Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J. Neurol. Neurosurg. Psychiatry 2002; 72: 12-21.
22. Menon V, Anagnoson RT, Glover GH, Pfefferbaum A. Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am. J. Psychiatry 2001; 158: 646-649.
23. Muller JL, Klein HE. Neuroleptic therapy influences basal ganglia activation: a functional magnetic resonance imaging study comparing controls to haloperidol- and olanzapine-treated inpatients. Psychiatry Clin. Neurosci. 2000; 54: 653-658.
24. Muller JL, Deuticke C, Putzhammer A, Roder CH, Hajak G, Winkler J. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study. Psychiatry Clin. Neurosci. 2003; 57: 562-568.
25. Eichhammer P, Wiegand R, Kharraz A, Langguth B, Binder H, Hajak G. Cortical excitability in neuroleptic-naive first-episode schizophrenic patients. Schizophr. Res. 2004; 67: 253-259.
26. Wiser AK, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Dysfunctional cortico-cerebellar circuits cause 'cognitive dysmetria' in schizophrenia. Neuroreport 1998; 9: 1895-1899.
27. Delevoye-Turrell Y, Giersch A, Danion JM. Abnormal sequencing of motor actions in patients with schizophrenia: evidence from grip force adjustments during object manipulation. Am. J. Psychiatry 2003; 160: 134-141.
28. Behrman AL, Teitelbaum P, Cauraugh JH. Verbal instructional sets to normalise the temporal and spatial gait variables in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1998; 65: 580-582.
29. Tonoya Y, Matsui M, Kurachi M, Kurokawa K, Sumiyoshi T. Exploratory eye movements in schizophrenia: effects of figure size and the instruction on visual search. Eur. Arch. Psychiatry Clin. Neurosci. 2002; 252: 255-261.
30. Jueptner M, Weiller C. A review of differences between basal ganglia and cerebellar control of movements as revealed by functional imaging studies. Brain 1998; 121: 1437-1449.
31. Halsband U, Matsuzaka Y, Tanji J. Neuronal activity in the primate supplementary, pre-supplementary and premotor cortex during externally and internally instructed sequential movements. Neurosci. Res. 1994; 20: 149-155.
32. Samuel M, Ceballos-Baumann AO, Blin J et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997; 120: 963-976.
33. Hanakawa T, Fukuyama H, Katsumi Y, Honda M, Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann. Neurol. 1999; 45: 329-336.